InsidersTradesSigma
Track the Shanghai Henlius Biotech, Inc. - H Shares stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Market capitalisation: €3.8bn. The latest transaction was reported on 10 July 2026 (Sale). Among the most active insiders: Zhu Jun. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Shanghai Henlius Biotech, Inc. is a China-based biopharmaceutical company focused on the development of biosimilar drugs. It specializes in the research and commercialization of treatments for cancer and other serious diseases.